{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:32:18Z","timestamp":1789014738410,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jtct.2023.10.018","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T21:20:08Z","timestamp":1698787208000},"page":"255-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"30","author":[{"given":"Lacey S.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Damm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie T.","family":"Deuitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosha","family":"Farhadfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Gergis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siob\u00e1n B.","family":"Keel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios V.","family":"Michelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya R.","family":"Panch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Sucheston-Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Tamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather E.","family":"Stefanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A.","family":"Godley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.10.018_bib0001","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/bmt.2016.18","article-title":"Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey","volume":"51","author":"Niederwieser","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.018_bib0002","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1309\/AJCPPJUQ9DNR1GHP","article-title":"Donor cell\u2013derived leukemias\/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature","volume":"135","author":"Wang","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtct.2023.10.018_bib0003","first-page":"969","article-title":"Development of leukemia in donor cells after allogeneic stem cell transplantation\u2014a survey of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"90","author":"Hertenstein","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.10.018_bib0004","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41375-018-0218-6","article-title":"European experience and risk factor analysis of donor cell-derived leukaemias\/MDS following haematopoietic cell transplantation","volume":"33","author":"Engel","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.10.018_bib0005","doi-asserted-by":"crossref","first-page":"346.e1","DOI":"10.1016\/j.jtct.2023.03.007","article-title":"Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"29","author":"Auletta","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.10.018_bib0006","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/s41409-021-01214-z","article-title":"Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome","volume":"56","author":"Williams","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.018_bib0007","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/leu.2016.23","article-title":"Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation","volume":"30","author":"Kato","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.10.018_bib0008","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbmt.2014.11.007","article-title":"Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study","volume":"21","author":"Bejanyan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.018_bib0009","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.bbmt.2016.08.002","article-title":"Identifying inherited and acquired genetic factors involved in poor stem cell mobilization and donor-derived malignancy","volume":"22","author":"Rojek","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.018_bib0010","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0140-6736(03)14797-6","article-title":"Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA","volume":"362","author":"Fogarty","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2023.10.018_bib0011","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1182\/blood-2008-05-156745","article-title":"Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy","volume":"112","author":"Owen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0012","doi-asserted-by":"crossref","first-page":"408.e1","DOI":"10.1016\/j.jtct.2022.03.029","article-title":"Systematic scoping review of studies reporting unexpected donor-derived abnormalities from recipients of allogeneic hematopoietic cell transplantation: a proposed framework for donor disclosure","volume":"28","author":"Candeliere","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.10.018_bib0013","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/bloodadvances.2020002803","article-title":"Multiple donor-derived leukemias in a recipient of allogeneic hematopoietic cell transplantation for myeloid malignancy","volume":"4","author":"Aldoss","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.10.018_bib0014","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(71)90998-6","article-title":"Leukaemic transformation of engrafted human marrow cells in vivo","volume":"1","author":"Fialkow","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2023.10.018_bib0015","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1056\/NEJM199006213222507","article-title":"Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia","volume":"322","author":"Niederwieser","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.10.018_bib0016","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbmt.2010.10.010","article-title":"Donor cell leukemia: a review","volume":"17","author":"Wiseman","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.018_bib0017","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.bbmt.2010.02.014","article-title":"Donor derived second hematologic malignancies after cord blood transplantation","volume":"16","author":"Ballen","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.018_bib0018","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bjh.12847","article-title":"Donor-derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response","volume":"166","author":"Dietz","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.10.018_bib0019","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.humimm.2021.07.013","article-title":"A practical guide to chimerism analysis: review of the literature and testing practices worldwide","volume":"82","author":"Blouin","year":"2021","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jtct.2023.10.018_bib0020","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/S2352-3026(17)30215-6","article-title":"Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study","volume":"5","author":"Williams","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2023.10.018_bib0021","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2006-07-021980","article-title":"Donor cell leukemia: insight into cancer stem cells and the stem cell niche","volume":"109","author":"Flynn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0022","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2022.05.006","article-title":"Clonal hematopoiesis: mutation-specific adaptation to environmental change","volume":"29","author":"Florez","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jtct.2023.10.018_bib0023","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nature20131","article-title":"Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment","volume":"539","author":"Dong","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2023.10.018_bib0024","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3324\/haematol.2016.158717","article-title":"An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemia","volume":"102","author":"Zhou","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.10.018_bib0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/bloodadvances.2022008172","article-title":"Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies","volume":"7","author":"Saygin","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.10.018_bib0026","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.2022016508","article-title":"Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes","volume":"140","author":"McReynolds","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0027","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1182\/blood-2010-12-326322","article-title":"First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation","volume":"117","author":"Xiao","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0028","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/leu.2017.44","article-title":"Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation","volume":"31","author":"Kobayashi","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.10.018_bib0029","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood-2018-07-861070","article-title":"Donor-derived MDS\/AML in families with germline GATA2 mutation","volume":"132","author":"Galera","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0030","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood.V98.9.2856","article-title":"A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies","volume":"98","author":"Buijs","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0031","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1756-8722-4-39","article-title":"Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms","volume":"4","author":"Diamond","year":"2011","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.10.018_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1084736","article-title":"Prioritization of patients for germline testing based on tumor profiling of hematopoietic malignancies","volume":"13","author":"Godley","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2023.10.018_bib0033","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood.2022015790","article-title":"Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages","volume":"140","author":"Feurstein","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0034","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41568-020-00315-z","article-title":"Advances in germline predisposition to acute leukaemias and myeloid neoplasms","volume":"21","author":"Klco","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtct.2023.10.018_bib0035","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/s41375-022-01729-4","article-title":"Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia","volume":"36","author":"Kubota","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.10.018_bib0036","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood.2021011354","article-title":"Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML","volume":"139","author":"Yang","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0037","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/humu.24374","article-title":"Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders","volume":"43","author":"DeRoin","year":"2022","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtct.2023.10.018_bib0038","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1182\/blood-2018-01-827881","article-title":"Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes","volume":"131","author":"Padron","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0039","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1172\/JCI91913","article-title":"Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans","volume":"127","author":"Buonocore","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2023.10.018_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1094260","article-title":"Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico","volume":"14","author":"D\u00edaz-Vel\u00e1squez","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.jtct.2023.10.018_bib0041","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ajcp\/aqab027","article-title":"Clinical and pathologic spectrum of DDX41-mutated hematolymphoid neoplasms","volume":"156","author":"Goyal","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtct.2023.10.018_bib0042","article-title":"Next-generation sequencing of DDX41 in myeloid neoplasms leads to increased detection of germline alterations","volume":"10","author":"Bannon","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2023.10.018_bib0043","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1097\/HS9.0000000000000321","article-title":"Nordic guidelines for germline predisposition to myeloid neoplasms in adults: recommendations for genetic diagnosis, clinical management and follow-up","volume":"3","author":"Baliakas","year":"2019","journal-title":"Hemasphere"},{"key":"10.1016\/j.jtct.2023.10.018_bib0044","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/bloodadvances.2020001927","article-title":"Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantation","volume":"4","author":"Martin","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.10.018_bib0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0046","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jacc.2019.06.007","article-title":"Clonal hematopoiesis: crossroads of aging, cardiovascular disease, and cancer: JACC Review Topic of the Week","volume":"74","author":"Libby","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtct.2023.10.018_bib0047","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1038\/s41375-021-01337-8","article-title":"Clonal hematopoiesis and its emerging effects on cellular therapies","volume":"35","author":"von Bonin","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.10.018_bib0048","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0049","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.10.018_bib0050","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.1038\/ncomms12484","article-title":"Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtct.2023.10.018_bib0051","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.10.018_bib0052","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","article-title":"Somatic mutations precede acute myeloid leukemia years before diagnosis","volume":"24","author":"Desai","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jtct.2023.10.018_bib0053","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","article-title":"Prediction of acute myeloid leukaemia risk in healthy individuals","volume":"559","author":"Abelson","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2023.10.018_bib0054","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtct.2023.10.018_bib0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41586-021-04312-6","article-title":"Life histories of myeloproliferative neoplasms inferred from phylogenies","volume":"602","author":"Williams","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2023.10.018_bib0056","doi-asserted-by":"crossref","first-page":"eaax6249","DOI":"10.1126\/scitranslmed.aax6249","article-title":"Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation","volume":"12","author":"Wong","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtct.2023.10.018_bib0057","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1200\/JCO.2018.79.2184","article-title":"Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation","volume":"37","author":"Frick","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.10.018_bib0058","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1182\/bloodadvances.2020003168","article-title":"Malignant progression of donor-engrafted clonal hematopoiesis in sibling recipients after stem cell transplantation","volume":"4","author":"Nevejan","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.10.018_bib0059","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1200\/JCO.21.02286","article-title":"Donor clonal hematopoiesis and recipient outcomes after transplantation","volume":"40","author":"Gibson","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.10.018_bib0060","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3324\/haematol.2022.281806","article-title":"Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up","volume":"108","author":"Kim","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.10.018_bib0061","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/leu.2013.278","article-title":"Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation","volume":"28","author":"Yasuda","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.10.018_bib0062","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3324\/haematol.2019.242347","article-title":"Donor cell leukemia: reappearance of gene mutations in donor cells - more than an incidental phenomenon?","volume":"105","author":"Shahar Gabay","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.10.018_bib0063","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/leu.2016.63","article-title":"Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation","volume":"30","author":"Gondek","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.10.018_bib0064","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/leu.2017.104","article-title":"Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient","volume":"31","author":"Herold","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.10.018_bib0065","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood.2019003079","article-title":"Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation","volume":"135","author":"Boettcher","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0066","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/leu.2015.67","article-title":"A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone","volume":"29","author":"Hahn","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.10.018_bib0067","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jtct.2023.10.018_bib0068","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtct.2023.10.018_bib0069","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D'Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.018_bib0070","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.bbmt.2015.08.009","article-title":"Suitability criteria for adult related donors: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues","volume":"21","author":"Worel","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.018_bib0071","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbmt.2018.02.006","article-title":"Development of an unrelated donor selection score predictive of survival after HCT: donor age matters most","volume":"24","author":"Shaw","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.018_bib0072","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.018_bib0073","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1200\/CCI.20.00185","article-title":"Optimal donor selection for hematopoietic cell transplantation using Bayesian machine learning","volume":"5","author":"Logan","year":"2021","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.jtct.2023.10.018_bib0074","article-title":"When a DNA test says you're a younger man, who lives 5,000 miles away","author":"Murphy","year":"2019","journal-title":"New York Times"},{"key":"10.1016\/j.jtct.2023.10.018_bib0075","unstructured":"National Marrow Donor Program. Be the Match. Training: Genetic mutation reporting process for transplant centers. December 7, 2022. Available at: https:\/\/network.bethematchclinical.org\/education\/education-catalog\/training-genetic-mutation-reporting-process-for-transplant-centers\/. Accessed May 13, 2023."},{"key":"10.1016\/j.jtct.2023.10.018_bib0076","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1002\/cncr.28807","article-title":"Genomic testing in cancer: patient knowledge, attitudes, and expectations","volume":"120","author":"Blanchette","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.10.018_bib0077","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/pbc.26137","article-title":"Patient\/parent perspectives on genomic tumor profiling of pediatric solid tumors: the Individualized Cancer Therapy (iCat) experience","volume":"63","author":"Marron","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.10.018_bib0078","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000327296","article-title":"Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants","volume":"15","author":"Gollust","year":"2012","journal-title":"Public Health Genomics"},{"key":"10.1016\/j.jtct.2023.10.018_bib0079","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s41436-021-01171-4","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jtct.2023.10.018_bib0080","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","article-title":"ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jtct.2023.10.018_bib0081","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0140-6736(97)08256-1","article-title":"Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants","volume":"351","author":"Wynn","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2023.10.018_bib0082","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723016408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723016408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:12:34Z","timestamp":1763003554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723016408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2666636723016408"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.10.018","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}